Senate Health Committee chairman Lamar Alexander (R, Tenn) and ranking member Patty Murray (D, Wash) introduced a budget amendment March 26 to promote the development and approval or licensure of safe and effective cutting-edge treatments.
“Today, discoveries supported by NIH [National Institutes of Health] often do not come to FDA’s [Food and Drug Administration’s] door for 6, 8, 10, or even 12 years, and the average cost to get a single drug from the laboratory through the approval process to the medicine cabinet is, according to some estimates, about $1 billion,” Alexander said in a statement (http://1.usa.gov/1ITYogk).
Rubin R. Senators Introduce Legislation to Streamline Development and Approval of New Treatments. JAMA. 2015;313(18):1787. doi:10.1001/jama.2015.4508